Clinical Report: Can red tattoos harbor keratoacanthoma?
Overview
A case report described a keratoacanthoma arising within red pigment in a recently placed forearm tattoo in a 61-year-old woman. The authors also cited 42 previously reported tattoo-associated keratoacanthomas and squamous cell carcinomas, 75% of which arose in red pigment; these reports do not establish incidence or causation.
Background
Keratoacanthoma is a squamous lesion that can be difficult to distinguish from cutaneous squamous cell carcinoma. Tattoo-associated cases have been reported, with a predominance in red pigment in the cited case literature. The reason for this pattern is incompletely understood; degradation of red azo pigments has been proposed as a possible contributor, but the mechanism has not been established. The current report concerns one patient and provides no comparative data or longitudinal follow-up.
Data Highlights
| Measure | Finding | Source context |
|---|---|---|
| Patient age and sex | 61-year-old woman | Single case report |
| Time since tattoo placement | 2 months | Right forearm tattoo |
| Lesion history and size | Rapidly growing for 6 weeks; 8 mm | Solitary crateriform nodule with central hyperkeratotic plug |
| Histopathology | Features consistent with keratoacanthoma; red tattoo pigment was present within tumor epithelium | Excision specimen |
| Previously published tattoo-associated cases | 42 keratoacanthomas and squamous cell carcinomas; 75% arose in red pigment | Both tumor types; not a new analysis in the case report |
Key Findings
- A 61-year-old woman presented with a rapidly growing, solitary 8-mm crateriform nodule within the red pigment of a forearm tattoo placed 2 months earlier.
- The lesion had a central hyperkeratotic plug, and excision showed histopathologic features consistent with keratoacanthoma.
- Histopathologic examination demonstrated red tattoo pigment deposits within the tumor epithelium.
- The authors identified 42 previously published tattoo-associated keratoacanthomas and squamous cell carcinomas; 75% arose within red pigment.
- The reported red-pigment proportion combines keratoacanthomas and squamous cell carcinomas and does not establish a keratoacanthoma-specific association or causal relationship.
- The authors described surgical excision as first-line treatment for solitary keratoacanthomas; the case report did not include longitudinal follow-up.
Conclusion
This case adds to reports of keratoacanthoma and squamous cell carcinoma arising in tattoos, often in red pigment. The available case-based evidence does not establish incidence, causation, or a mechanism.
Related Resources & Content
- Jackson EK et al., Skin Health and Disease, 2026 -- Keratoacanthoma in a red tattoo
- European consensus-based interdisciplinary guideline, 2026 -- European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026
- ASCO Publications — Actinic keratosis as a premalignant lesion: Systematic review and meta-analysis of topical field–directed therapy versus vehicle/placebo.
- Ophthalmology Management — PEARLS FOR ACANTHAMOEBA KERATITIS
- the new optometrist — Warning Coloration
- ASCO Publications — Presence of frequent underlying RAS mutations in cutaneous squamous cell carcinomas and keratoacanthomas (cuSCC/KA) that develop in patients during vemurafenib therapy.
- Keratoacanthoma in a red tattoo
- European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026
- European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026
- Keratoacanthoma in a red tattoo
- Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
